Scientific Reports · 2016 · 66 citations · 34 references
PharmacyOncologyPharmaceuticsApoptosisDrug DeliveryTargeted Drug DeliveryAntimicrobial PeptidesCancer Drug DeliveryCell-penetrating PeptidesPeptide ChemistryPeptide DeliveryPh-responsive Drug DeliveryAcidic Tumor MicroenvironmentCationic Antimicrobial PeptidesPeptide ConjugatesPeptide ConjugationPeptide-drug ConjugatesTargeted DeliveryTargeted Delivery SystemsTumor-targeting Peptides
Positively charged antimicrobial peptides have become promising agents for the treatment of cancer by inducing apoptosis though their preferential binding and disruption of negatively charged membranes, such as the mitochondrial membrane. (KLAKLAK)2 is such a peptide but due to its polarity, it cannot cross the cellular membrane and therefore relies on the use of a delivery agent. For targeted delivery, previous studies have relied on cell penetrating peptides, nanoparticles or specific biomarkers. Herein, we investigated the first use of pHLIP to selectively target and directly translocate (KLAKLAK)2 into the cytoplasm of breast cancer cells, based on the acidic tumor micro-environment. With the goal of identifying a lead conjugate with optimized selective cytotoxicity towards cancer cells, we analyzed a family of (KLAKLAK)2 analogs with varying size, polarity and charge. We present a highly efficacious pHLIP conjugate that selectively induces concentration- and pH-dependent toxicity in breast cancer cells.
34
Endonuclease G is an apoptotic DNase when released from mitochondria
Lily Y. Li, Xu Luo, Xiaodong Wang · Nature · 2001 · 1.7K citations
Anti-cancer activity of targeted pro-apoptotic peptides
H. Michael Ellerby, Wadih Arap, Lisa Ellerby et al. · Nature Medicine · 1999 · 930 citations
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Christopher J. Cheng, Raman Bahal, Imran Babar et al. · Nature · 2014 · 841 citations
Medicine, Cancer Biology, Oncology +14